<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03087266</url>
  </required_header>
  <id_info>
    <org_study_id>3399/11_A</org_study_id>
    <nct_id>NCT03087266</nct_id>
  </id_info>
  <brief_title>Acute-phase Response &amp; Periodontal Treatment in Diabetes Affected Patients</brief_title>
  <acronym>PERIO-DIA</acronym>
  <official_title>Acute-phase Response Following Full-mouth Versus Quadrant Non-surgical Periodontal Treatment in Diabetes-affected Subjects: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pisa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pisa</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thirty-eight periodontitis- and diabetes-affected subjects will be randomly allocated to non&#xD;
      surgical periodontal treatment with either Full-Mouth Approach (FM-SRP) or Quadrant approach&#xD;
      (Q-SRP).&#xD;
&#xD;
      Patients will be seen one day and three months (study completion) after treatment. The 24&#xD;
      hours appointment will be occurring after the entire completion of the FM-SRP or the first&#xD;
      quadrant of the Q-SRP. In the latter group other sessions of treatment will be performed&#xD;
      within the following 3 weeks.&#xD;
&#xD;
      At baseline, 24 hours and three months, anthropometric, inflammatory and endothelial&#xD;
      parameters will be collected. Periodontal parameters will be checked at baseline and at three&#xD;
      months.&#xD;
&#xD;
      Main outcome of the study is the level of C-reactive protein 24 hours after treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Actual">November 2020</completion_date>
  <primary_completion_date type="Actual">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>single-centre randomized controlled clinical trial with a 3- month follow-up</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Levels C-Reactive Protein</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in C reactive protein (CRP). Unit of measure: mg/L</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Full Mouth Plaque Score (FMPS)</measure>
    <time_frame>Baseline and 3 months after treatment</time_frame>
    <description>Changes in FMPS. Unit of Measure: %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Full Mouth Bleeding Score (FMBS)</measure>
    <time_frame>Baseline and 3 months after treatment</time_frame>
    <description>Changes in FMBS. Unit of Measure: %</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pocket probing depth (PPD)</measure>
    <time_frame>Baseline and 3 months after treatment</time_frame>
    <description>Changes in PPD. Unit of measure: mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical attachment level (CAL)</measure>
    <time_frame>Baseline and 3 months after treatment</time_frame>
    <description>Changes in CAL. Unit of measure: mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recession of the gingival margin (REC)</measure>
    <time_frame>Baseline and 3 months after treatment</time_frame>
    <description>Changes in REC. Unit of measure: mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in triglycerides. Unit of measure: mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low-density lipoprotein (LDL)</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in LDL. Unit of measure: mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High-density lipoprotein (HDL)</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in HDL. Unit of measure: mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cholesterol</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in total cholesterol, Unit of measure: mmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemia</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in blood glucose level. Unit of measure: mg/dl</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycated Haemoglobin</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in Glycated haemoglobin. Unit of measure: mmol/mol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in Insulin level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure (SBP)</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in SBP Unit of measure: mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure (DBP)</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Changes in DBP. Unit of measure: mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial Function</measure>
    <time_frame>Baseline, 24 hours and 3 months after treatment</time_frame>
    <description>Measures of endothelial function taken through Flow-Mediated dilation. Unit of Measure: %</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">38</enrollment>
  <condition>Periodontitis</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Full- Mouth Scaling and Root Planing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>FM-SRP Non-surgical periodontal treatment will be performed in all dentition within 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quadrant Scaling and Root Planing</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Q-SRP Non-surgical periodontal treatment will be performed in all dentition subdivided in four appointments. Each appointment will be performed with one week interval. In each appointment only a &quot;quadrant&quot; of the dentition will be instrumented.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>FM-SRP</intervention_name>
    <description>Non surgical periodontal treatment performed in all dentition within 1-2 appointments in a 24 hour time frame.</description>
    <arm_group_label>Full- Mouth Scaling and Root Planing</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Q-SRP</intervention_name>
    <description>Non surgical periodontal treatment performed in 4 sessions comprising of a quadrant (1/4) of the dentition each. Performed in 3 weeks time frame.</description>
    <arm_group_label>Quadrant Scaling and Root Planing</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients affected by Periodontal disease&#xD;
&#xD;
          -  20% of periodontal pockets of the entire dentition&#xD;
&#xD;
          -  20% bleeding on probing of the entire dentition&#xD;
&#xD;
          -  documented radiographic bone loss&#xD;
&#xD;
          -  Diagnosis of Diabetes Type 2 as measured through international standards&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age younger than 18 years and older than 80 years&#xD;
&#xD;
          -  pregnant or lactating females&#xD;
&#xD;
          -  females using contraceptive methods&#xD;
&#xD;
          -  need of antibiotic coverage for periodontal treatment&#xD;
&#xD;
          -  previous periodontal treatment in the last 6 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Filippo Graziani, DDS, MClinDent, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pisa</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital of Pisa</name>
      <address>
        <city>Pisa</city>
        <zip>56126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>March 7, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2017</study_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pisa</investigator_affiliation>
    <investigator_full_name>Filippo Graziani, DDS MClinDent PhD</investigator_full_name>
    <investigator_title>Professor of Periodontology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Acute-Phase Reaction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

